About: Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique (publié 2005) (fr) наукова стаття, опублікована в січні 2005 (uk) artículu científicu espublizáu en xineru de 2005 (ast) artikull shkencor i botuar më 01 janar 2005 (sq) scientific article published on 01 January 2005 (en)
publication date	wds:Q81277909-77A6E11C-EE4E-4724-96AD-6E2F4E54344D
publication date	2005-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q81277909-134894B8-02EA-467A-88CF-3241CB9290C1 wds:Q81277909-249087C1-C1EC-4705-921E-179A69773C09 wds:Q81277909-26A6FB6D-45C6-42E1-AD32-3E711215039A wds:Q81277909-3BEA1482-BBF7-4568-A9F8-D6314AED449A wds:Q81277909-7B4FF4AD-4F6F-42B9-945C-C4888F809F3F wds:Q81277909-7B85825E-7AA0-4CA5-A4EE-C997C0E455CD wds:Q81277909-9E41A04F-673B-4D2E-A26A-6D7823772191 wds:Q81277909-B84F24CF-F7B7-42F8-B3B2-04F544772556 wds:Q81277909-B95AE4D8-A1AC-4C06-82B6-1DD6991B8293 wds:Q81277909-CE5A0552-DF70-43B2-A66B-4F340AE23272 wds:Q81277909-D903EB34-F59E-4140-9647-5CA0877B57AA wds:Q81277909-E2866453-63D3-420B-81FC-0A232DF1C84F
author name string	Jack Lawler Robert S Kerbel Daniel J Dumont Yuval Shaked Jack Henkin Daniel Voskas Yaacov Ben-David Shan Man Dave Cervi Robert J D'Amato Jim Huber Kimberley Rawn
rdfs:label	Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (en) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (nl) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (sq)
skos:prefLabel	Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (en) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (nl) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (sq)
name	Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (en) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (nl) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (sq)
author	wds:Q81277909-75C7EFFC-726B-4A2F-B66C-33164A723A60 wds:Q81277909-CAD13F79-E1A2-4EA1-AFD0-44ABD4F3926B wds:Q81277909-CB135662-579E-4998-BF34-E65E4127DE67 wds:Q81277909-F55BA6A2-AFF8-4589-9412-A7B81E2B67D1
author	Daniel J. Hicklin Francesco Bertolini Thomas Foutz Michael S. Rogers
title	wds:Q81277909-4A51C39F-E486-4705-A1EA-61F7F13D481C
title	Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis (en)
page(s)	wds:Q81277909-DA9EDAA8-FFD8-4A1B-9110-8FD516308448
page(s)	101-111
instance of	wds:Q81277909-2F9AFB58-0C2A-4DFF-8AAE-7998E3C90860
instance of	scholarly article
main subject	wds:Q81277909-1B94E6E4-87B0-410F-83DF-02818F4E6710 wds:Q81277909-5446D850-4C0E-45A2-93AF-A80A6280F33C wds:Q81277909-63E95AFE-CBA2-483A-ACDE-818AF8976087 wds:Q81277909-A805BE3A-DD8D-4CBF-B942-2FAF00A0FDC4
main subject	phenotype angiogenesis vasculogenesis heterogeneity
PubMed ID	wds:Q81277909-EFF3C419-0695-49EB-9666-E339A918645B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15652753
PubMed ID	15652753
published in	wds:Q81277909-B5A32A3B-2F82-40CA-BB0F-628C8018988C
published in	Cancer Cell
issue	wds:Q81277909-80843047-2C81-4766-8EA7-45C661A8961E
volume	wds:Q81277909-7B590EEC-6AA5-4951-87C3-493021406F7E
issue	1
volume	7
DOI	wds:Q81277909-F15550A0-CF76-41E5-B481-36E2E3952D02
DOI	http://dx.doi.org/10.1016/S1535-6108(04)00369-1
DOI	10.1016/S1535-6108(04)00369-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81277909
is cites work of	Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Metronomic chemotherapy: changing the paradigm that more is better Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer The albino mutation of tyrosinase alters ocular angiogenic responsiveness Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224) Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice The effect of thrombospondin-1 on breast cancer metastasis In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages Thrombospondin-based antiangiogenic therapy Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents. Tumor angiogenesis Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity. Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs Clinical biomarkers of angiogenesis inhibition

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software